MedTrace Logo

Lidocaine Gel During Transrectal Sonography

NCT02567838 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-03-27

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate the use of topical lidocaine gel in reducing pain associated with transrectal ultrasonography (TRS) in gynecologic field.

Conditions

  • Gynecologic Diseases

Interventions

DRUG

Lidocaine gel

Instillagel (2% lidocaine) was administered rectally prior to probe insertion.

DRUG

Placebo

Placebo (Aquagel) was administered rectally prior to probe insertion.

Sponsors & Collaborators

  • Kangbuk Samsung Hospital

    lead OTHER

Principal Investigators

  • Taejong Song, MD PhD · Kangbuk Samsung Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567838 on ClinicalTrials.gov